Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Q32 Bio (QTTB) Change in Account Payables (2017 - 2025)

Q32 Bio (QTTB) has 9 years of Change in Account Payables data on record, last reported at -$94000.0 in Q4 2025.

  • For Q4 2025, Change in Account Payables fell 105.43% year-over-year to -$94000.0; the TTM value through Dec 2025 reached -$2.1 million, down 102.3%, while the annual FY2025 figure was -$2.1 million, 102.3% down from the prior year.
  • Change in Account Payables reached -$94000.0 in Q4 2025 per QTTB's latest filing, down from $63000.0 in the prior quarter.
  • Across five years, Change in Account Payables topped out at $7.7 million in Q1 2022 and bottomed at -$6.1 million in Q2 2022.
  • Average Change in Account Payables over 5 years is -$229400.0, with a median of -$97000.0 recorded in 2021.
  • Peak YoY movement for Change in Account Payables: surged 7801.0% in 2022, then plummeted 2850.0% in 2024.
  • A 5-year view of Change in Account Payables shows it stood at -$1.4 million in 2021, then tumbled by 170.67% to -$3.7 million in 2022, then surged by 144.39% to $1.6 million in 2023, then rose by 5.61% to $1.7 million in 2024, then tumbled by 105.43% to -$94000.0 in 2025.
  • Per Business Quant database, its latest 3 readings for Change in Account Payables were -$94000.0 in Q4 2025, $63000.0 in Q3 2025, and -$1.8 million in Q2 2025.